In the general news, David Cameron won reelection in Great Britain, as did the Scottish party that wants to become an independent country. In the U.S., the NSA phone spying program was ruled illegal by an appeals court vindicating Ed Snowden, and 223,000 jobs were added in April, marking a rebound after the cold winter had stalled hirin
In healthcare business news, Alexion (ALXN) acquired Synageva (GEVA) for $8.4 billion to expand into the orphan drug markets which enjoy unabated high pricing power. Thoratec (THOR) continued its rebound with good earnings. MannKind (MNKD) announced that the Afrezza launch was a dismal failure and blamed the respiratory tests required before prescribing.
News from the medical meetings circuit was quiet. Also, there were no major decisions made by the FDA.